{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T13:34:09Z","timestamp":1766237649894,"version":"3.48.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,20]]},"DOI":"10.7759\/cureus.99692","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T13:32:50Z","timestamp":1766237570000},"source":"Crossref","is-referenced-by-count":0,"title":["A New WHO Entity of SMARCB1\/INI1-Deficient Undifferentiated Thoracic Tumors: Rare, Aggressive, and Overlooked"],"prefix":"10.7759","author":[{"given":"Chaimae","family":"Bekhakh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anass","family":"Haloui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Bakhti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassira","family":"Karich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Bennani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22691","article-title":"The roles of the SWI\/SNF complex in cancer","volume":"131","author":"Schaefer IM","year":"2023","unstructured":"Schaefer IM, Qian X. The roles of the SWI\/SNF complex in cancer. Cancer Cytopathol. 2023, 131:410-4. 10.1002\/cncy.22691","journal-title":"Cancer Cytopathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2014.04.004","article-title":"Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth","volume":"207","author":"Kim KH","year":"2014","unstructured":"Kim KH, Roberts CW. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth. Cancer Genet. 2014, 207:365-72. 10.1016\/j.cancergen.2014.04.004","journal-title":"Cancer Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-955","article-title":"SMARCB1\/INI1-deficient undifferentiated tumour of the thorax: a case report and review of the literature","volume":"116","author":"Zagni M","year":"2024","unstructured":"Zagni M, Marando A, Negrelli M, et al.. SMARCB1\/INI1-deficient undifferentiated tumour of the thorax: a case report and review of the literature. Pathologica. 2024, 116:163-9. 10.32074\/1591-951X-955","journal-title":"Pathologica"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13173","article-title":"Oncogenic roles of SMARCB1\/INI1 and its deficient tumors","volume":"108","author":"Kohashi K","year":"2017","unstructured":"Kohashi K, Oda Y. Oncogenic roles of SMARCB1\/INI1 and its deficient tumors. Cancer Sci. 2017, 108:547-52. 10.1111\/cas.13173","journal-title":"Cancer Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.24808.2","article-title":"SMARCB1\/INI1-deficient tumors of adulthood","volume":"9","author":"Parker NA","year":"2020","unstructured":"Parker NA, Al-Obaidi A, Deutsch JM. SMARCB1\/INI1-deficient tumors of adulthood. F1000Res. 2020, 9:662. 10.12688\/f1000research.24808.2","journal-title":"F1000Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4321-x","article-title":"The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report","volume":"18","author":"Yoshida K","year":"2018","unstructured":"Yoshida K, Fujiwara Y, Goto Y, Kohno T, Yoshida A, Tsuta K, Ohe Y. The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report. BMC Cancer. 2018, 18:398. 10.1186\/s12885-018-4321-x","journal-title":"BMC Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-022-01133-4","article-title":"Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic neoplasms","volume":"35","author":"Haberecker M","year":"2022","unstructured":"Haberecker M, B\u00fchler MM, Mendieta AP, et al.. Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic neoplasms. Mod Pathol. 2022, 35:1860-9. 10.1038\/s41379-022-01133-4","journal-title":"Mod Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112151-20220207-00076","article-title":"[INI1 (SMARCB1) deletion of lung cancer: report of a case]","volume":"51","author":"Zhou YH","year":"2022","unstructured":"Zhou YH, Qin S, Yan JX, Ji J, Lan T, Liu Y. [INI1 (SMARCB1) deletion of lung cancer: report of a case]. Zhonghua Bing Li Xue Za Zhi. 2022, 51:902-4. 10.3760\/cma.j.cn112151-20220207-00076","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2021.11.010","article-title":"SMARCB1\/INI1-deficient primary lung carcinoma with hepatic metastasis","volume":"54","author":"Rickard JA","year":"2022","unstructured":"Rickard JA, Burr ML, Williams B, Murugasu A, Fellowes A, John T, Christie M. SMARCB1\/INI1-deficient primary lung carcinoma with hepatic metastasis. Pathology. 2022, 54:817-20. 10.1016\/j.pathol.2021.11.010","journal-title":"Pathology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1088534","article-title":"STK11 loss and SMARCB1 deficiency mutation in a dedifferentiated lung cancer patient present response to neo-adjuvant treatment with pembrolizumab and platinum doublet: a case report","volume":"13","author":"Chen J","year":"2023","unstructured":"Chen J, Wang J. STK11 loss and SMARCB1 deficiency mutation in a dedifferentiated lung cancer patient present response to neo-adjuvant treatment with pembrolizumab and platinum doublet: a case report. Front Oncol. 2023, 13:1088534. 10.3389\/fonc.2023.1088534","journal-title":"Front Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.07.018","article-title":"Vulnerabilities of mutant SWI\/SNF complexes in cancer","volume":"26","author":"Helming KC","year":"2014","unstructured":"Helming KC, Wang X, Roberts CW. Vulnerabilities of mutant SWI\/SNF complexes in cancer. Cancer Cell. 2014, 26:309-17. 10.1016\/j.ccr.2014.07.018","journal-title":"Cancer Cell"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43498-3","article-title":"SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors","volume":"14","author":"Liu NQ","year":"2023","unstructured":"Liu NQ, Paassen I, Custers L, et al.. SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors. Nat Commun. 2023, 14:7762. 10.1038\/s41467-023-43498-3","journal-title":"Nat Commun"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdae162","article-title":"Development and epigenetic regulation of atypical teratoid\/rhabdoid tumors in the context of cell-of-origin and halted cell differentiation","volume":"6","author":"Huhtala L","year":"2024","unstructured":"Huhtala L, Karabiyik G, Rautajoki KJ. Development and epigenetic regulation of atypical teratoid\/rhabdoid tumors in the context of cell-of-origin and halted cell differentiation. Neurooncol Adv. 2024, 6:vdae162. 10.1093\/noajnl\/vdae162","journal-title":"Neurooncol Adv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115727","article-title":"Targeting EZH2 in SMARCB1-deficient sarcomas: advances and opportunities to potentiate the efficacy of EZH2 inhibitors","volume":"215","author":"Lanzi C","year":"2023","unstructured":"Lanzi C, Arrighetti N, Pasquali S, Cassinelli G. Targeting EZH2 in SMARCB1-deficient sarcomas: advances and opportunities to potentiate the efficacy of EZH2 inhibitors. Biochem Pharmacol. 2023, 215:115727. 10.1016\/j.bcp.2023.115727","journal-title":"Biochem Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf121","article-title":"Thoracic SMARCA4-deficient undifferentiated tumor: diagnostic characteristics, molecular insights, and treatment approaches","volume":"30","author":"Song J","year":"2025","unstructured":"Song J, Gersten A, Herzberg B, Halmos B. Thoracic SMARCA4-deficient undifferentiated tumor: diagnostic characteristics, molecular insights, and treatment approaches. Oncologist. 2025, 30:oyaf121. 10.1093\/oncolo\/oyaf121","journal-title":"Oncologist"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/446641-a-new-who-entity-of-smarcb1ini1-deficient-undifferentiated-thoracic-tumors-rare-aggressive-and-overlooked","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T13:32:52Z","timestamp":1766237572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/446641-a-new-who-entity-of-smarcb1ini1-deficient-undifferentiated-thoracic-tumors-rare-aggressive-and-overlooked"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.99692","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,20]]}}}